Emergency coronary artery bypass surgery for percutaneous coronary interventions - Changes in the incidence, clinical characteristics, and indications from 1979 to 2003

被引:107
作者
Yang, EH [1 ]
Gumina, RJ [1 ]
Lennon, RJ [1 ]
Holmes, DR [1 ]
Rihal, CS [1 ]
Singh, M [1 ]
机构
[1] Mayo Coll Med, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA
关键词
D O I
10.1016/j.jacc.2005.06.083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The purpose of the current study was to evaluate the changes in incidence, clinical characteristics, and indications for emergency coronary artery bypass grafting (CABG) in patients undergoing percutaneous coronary intervention (PCI) from 1979 to 2003. BACKGROUND Emergency CABG after PCI is associated with significant morbidity and mortality. METHODS Data from 23,087 patients who underwent PCI at Mayo Clinic from 1979 to 2003 were analyzed. Patients were divided into three groups: the "pre-stent" era, 1979 to 1994 (n = 8,905); the "initial stent era," 1995 to 1999 (n = 7,605); and the "current stent era," 2000 to 2003 (n = 6,577). RESULTS Although patients undergoing PCI in the recent time periods had more high-risk features, there was a significant decrease in the incidence of emergency CABG from 2.9% to 0.7% to 0.3% across the groups (p < 0.001). Patients requiring emergency surgery in the recent time periods had a higher prevalence of hypertension, prior revascularization, and left ventricular dysfunction (ejection fraction < 40%), as well as more complex coronary lesions. Fewer patients in the current stent era had coronary artery dissections and abrupt vessel closure requiring emergency CABG. The in-hospital mortality rate for emergency CABG patients remains unchanged and ranges from 10% to 14%. CONCLUSIONS The current study demonstrates that despite the increase in high-risk patients undergoing PCI, there has been a marked decrease in the incidence of patients requiring emergency CABG. However, the in-hospital mortality rate for those requiring emergency CABG remains high and unchanged.
引用
收藏
页码:2004 / 2009
页数:6
相关论文
共 16 条
[1]   Reduction in angioplasty complications after the introduction of coronary stents: Results from a consecutive series of 2242 patients [J].
Altmann, DB ;
Racz, M ;
Battleman, DS ;
Bergman, G ;
Spokojny, A ;
Hannan, EL ;
Sanborn, TA .
AMERICAN HEART JOURNAL, 1996, 132 (03) :503-507
[2]   Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT-(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II trial [J].
Blankenship, JC ;
Sigmon, KN ;
Pieper, KS ;
O'Shea, C ;
Tardiff, BE ;
Tcheng, JE .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (09) :969-973
[3]   RISK ANALYSIS OF OPERATIVE INTERVENTION FOR FAILED CORONARY ANGIOPLASTY [J].
BORKON, AM ;
FAILING, TL ;
PIEHLER, JM ;
KILLEN, DA ;
HOSKINS, ML ;
REED, WA ;
MACKENZIE, JW ;
FIORE, AC ;
CLARK, RE .
ANNALS OF THORACIC SURGERY, 1992, 54 (05) :884-891
[4]  
COWLEY MJ, 1984, AM J CARDIOL, V53, P22
[5]   EMERGENCY CORONARY-ARTERY BYPASS-SURGERY FOR FAILED PERCUTANEOUS CORONARY ANGIOPLASTY - A 10-YEAR EXPERIENCE [J].
CRAVER, JM ;
WEINTRAUB, WS ;
JONES, EL ;
GUYTON, RA ;
HATCHER, CR .
ANNALS OF SURGERY, 1992, 215 (05) :425-434
[6]   Factors influencing mortality after emergency coronary artery bypass grafting for failed percutaneous transluminal coronary angioplasty [J].
Lazar, HL ;
Jacobs, AK ;
Aldea, GS ;
Shapira, OM ;
Lancaster, D ;
Shemin, RJ .
ANNALS OF THORACIC SURGERY, 1997, 64 (06) :1747-1752
[7]  
MOLITERNO DJ, 2003, J AM COLL CARDIOL, V41, P19
[8]   Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention - The ESPRIT trial: A randomized controlled trial [J].
O'Shea, JC ;
Hafley, GE ;
Greenberg, S ;
Hasselblad, V ;
Lorenz, TJ ;
Kitt, MM ;
Strony, J ;
Tcheng, JE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2468-2473
[9]  
PARSONNET V, 1988, J THORAC CARDIOV SUR, V96, P198